A Comparison of the Effects of Empagliflozin and Sitagliptin, When Combined With Metformin, on Lipid Levels in Patients with Type 2 Diabetes: A Clinical Investigation

Introduction Type 2 diabetes (T2D) is emerging as a major global health concern. An associated condition, dyslipidemia, which acts as a significant modifiable risk factor for T2D, exhibits variations across different ethnicities and socioeconomic backgrounds. While many patients rely on metformin as...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Mazhar, Saeed, Asjad, Khan, Muhammad Zarar, Javaid, Sana Z, Aslam, Farhan, Dar, Savida Ilyas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552574/
https://www.ncbi.nlm.nih.gov/pubmed/37809225
http://dx.doi.org/10.7759/cureus.44709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552574/
https://www.ncbi.nlm.nih.gov/pubmed/37809225
http://dx.doi.org/10.7759/cureus.44709

Ejemplares similares